Jaewon Choi

TL;DR: Using RT-PCR analysis, the expression levels of cytokines and growth factors from MSCs and their differentiated cell types, including osteoblasts, adipocytes and endothelial cells are examined to help determine future clinical applications of MSCS and their derivatives for cell therapy.

TL;DR: It is suggested that Livin expression is a novel prognostic marker in childhood ALL and thus needs to be incorporated into the patient stratification and treatment protocols.

TL;DR: This is the first study demonstrating the prognostic implication of theApollon expression in human cancers, indicating that Apollon overexpression may be used as a poor prognostic marker in childhood acute myeloid leukemia through validation by further studies.

TL;DR: The results suggest that the optimal ratio of HSCs and MSCs for cotransplantation might be in the range of 1:8-1:16; whereas, an excessive dose of M SCs might decrease engraftment efficiency.

TL;DR: In 53 children with de novo AML, the level of XIAP expression was determined by using quantitative reverse transcriptase-polymerase chain reaction and was analyzed with respect to the clinical characteristics at diagnosis and treatment outcomes and revealed that XIAP overexpression was an independent unfavorable prognostic factor for relapse-free survival.